GlobeNewsWire
02 Jul 2026, 12:45 UTC · 1h ago
Cannabix Technologies Announces Detection of Methamphetamine and Amphetamine in Human Breath
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
GlobeNewsWire
02 Jul 2026, 12:45 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Cannabix Technologies has successfully detected methamphetamine and amphetamine compounds in human breath samples using its existing MBT technology. — This expands the company's addressable market from cannabis-only testing to a broader range of illicit stimulants, increasing potential revenue streams.
+0.60The company intends to expand the use of the Cannabix MBT beyond THC to target workplace safety, transportation, and law enforcement customers. — Diversifying the product application into safety-sensitive industries provides a path for growth and reduces reliance on a single drug-testing niche.
+0.40The results were validated by Omega Laboratories Inc. using liquid chromatography-mass spectrometry (LC-MS). — Third-party laboratory validation using industry-standard methods adds scientific credibility to the company's claims.
+0.30Which stocks this story touches
Continue reading
6 related stories
Search tags
The company announced a significant technological breakthrough in detecting methamphetamine and amphetamines, expanding its potential market value.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
3h ago
